Loading provider…
Loading provider…
Cardiovascular Disease Physician in Ventura, CA
NPI: 1457650038Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get M.D. Timothy's Phone Numberphone_androidMobile
Get M.D. Timothy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2013 - 2027
CA State Medical License

American Board of Internal Medicine
Cardiovascular Disease

American Board of Internal Medicine
Interventional Cardiology
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 2011
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Interventional Cardiology
2017 - 2018
Fellowship • Cardiovascular Disease
2014 - 2017
Residency • Internal Medicine
2011 - 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 458 | 478 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 397 | 678 |
| 3 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 395 | 471 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 362 | 488 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 157 | 216 |
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer.
Authors: Andre Akhondi, Gregory Glover, Joshua Rosenberg, Megha Agarwal, Nidhi Thareja
Journal: Curr Oncol Rep
Publication Date: 2019-08-24
Pleural effusions, eosinophilia and a positive interferon-γ release assay.
Authors: Michael Roth
Publication Date: 2013-01
Authors: Jonathan Tobis, Daniel Jurewitz, Ravi Bhatia
Journal: J Invasive Cardiol
Lead Sponsor: SCAD Alliance
Collaborators: PERFUSE Study Group